Mainz Biomed N.V. (MYNZ)
NASDAQ: MYNZ · Real-Time Price · USD
1.550
0.00 (0.00%)
At close: Sep 26, 2025, 4:00 PM EDT
1.580
+0.030 (1.94%)
After-hours: Sep 26, 2025, 6:21 PM EDT
Mainz Biomed Market Cap
Mainz Biomed has a market cap or net worth of $5.33 million as of September 26, 2025. Its market cap has decreased by -22.74% in one year.
Market Cap
5.33M
Enterprise Value
6.51M
1-Year Change
-22.74%
Ranking
Category
Stock Price
$1.55
Market Cap Chart
Since the IPO on November 5, 2021, Mainz Biomed's market cap has decreased from $58.55M to $5.33M, a decrease of -90.89%. That is a compound annual growth rate of -45.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 5.33M | -63.37% |
| Dec 31, 2024 | 14.55M | -38.37% |
| Dec 29, 2023 | 23.62M | -77.05% |
| Dec 30, 2022 | 102.90M | -17.54% |
| Dec 31, 2021 | 124.78M | 113.12% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 650.45B |
| Johnson & Johnson | 432.80B |
| AbbVie | 389.72B |
| UnitedHealth Group | 311.62B |
| Novo Nordisk | 242.68B |
| Novartis AG | 238.65B |
| Abbott Laboratories | 232.44B |
| AstraZeneca | 228.75B |